| abstract |
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of autoimmune diseases and/or inflammatory diseases, graft versus host disease, cancers, central nervous diseases including neurodegenerative diseases and the like, and a medicament comprising the compound. n The present invention relates to a compound represented by the formula (I): n nwherein each symbol is as defined in the specification, or a salt thereof. |